Brown J, Dollery C, Valdes G
Am J Med. 1986 Aug 25;81(2B):43-57. doi: 10.1016/0002-9343(86)90907-1.
Indomethacin and some other nonsteroidal anti-inflammatory drugs partially antagonize the blood pressure lowering effect of drugs used to treat hypertension. They can also produce a mild elevation of blood pressure in normotensive individuals. The elevated arterial pressure caused by these agents is associated with increases in the vascular resistance of mainly the renal and splanchnic beds. This may be due to direct inhibition of the synthesis of vasodilator prostanoids, or it may be due to indirect potentiation of the action of the sympathetic nervous system or of angiotensin II. Nonsteroidal anti-inflammatory drugs also cause renal retention of sodium and this probably contributes to their hypertensive effects. In humans, the sodium retention may involve increased reabsorption in the proximal tubule. Although a direct tubular action is possible, these drugs may change proximal sodium reabsorption by their vascular effects. However, the exact mechanism is not understood. These interactions are clinically significant and may complicate the treatment of common diseases.
吲哚美辛和其他一些非甾体抗炎药会部分拮抗用于治疗高血压的药物的降压效果。它们还可使血压正常的个体血压轻度升高。这些药物引起的动脉血压升高与主要是肾和内脏血管床的血管阻力增加有关。这可能是由于直接抑制血管舒张性前列腺素的合成,或者可能是由于间接增强交感神经系统或血管紧张素II的作用。非甾体抗炎药还会导致肾脏钠潴留,这可能促成了它们的升压作用。在人类中,钠潴留可能涉及近端小管重吸收增加。虽然可能存在直接的肾小管作用,但这些药物可能通过其血管效应改变近端钠重吸收。然而,确切机制尚不清楚。这些相互作用具有临床意义,可能会使常见疾病的治疗复杂化。